Golden
Nuclera Nucleics

Nuclera Nucleics

Nuclera Nucleics is a Cambridge, UK based DNA synthesis biotechnology company

All edits

Edits on 30 Jan 2019
Baye Maniago"Approved suggestion from source: http://www.nuclera.com"
Baye Maniago approved a suggestion from Golden's AI on 30 Jan 2019 7:27 pm
Edits made to:
Infobox (+1 properties)
Edits on 21 Jan 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 Jan 2019 10:17 pm
Edits on 9 Jan 2019
Golden AI
Golden AI edited on 9 Jan 2019 11:59 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 13 Dec 2018
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 13 Dec 2018 5:15 pm
Edits made to:
Article (+13/-13 characters)

Article

Nuclera is a DNA synthesisDNA synthesis company working on the synthesis of long DNA strands. Nuclera's water-based DNA synthesis and automation platform is based on engineered terminal deoxynucleotidyl transferases (TdT) to enable the production of gene and genome libraries. Their TdT enzymes incorporate reversibly terminating nucleotide triphosphates of the four nucleobases. Nuclera aims to provide long-length (longer than 500 nucleotides) variant DNA and genome libraries for protein, biological pathway, and genome-scale engineering.

Edits on 12 Dec 2018
Golden AI"Import data"
Golden AI edited on 12 Dec 2018 1:05 am
Edits made to:
Infobox (+2 properties)
Categories (+1 topics)
Edits on 9 Oct 2018
Carla Faraguna
Carla Faraguna edited on 9 Oct 2018 4:55 pm
Edits made to:
Infobox (+1 properties)
Description (+20 characters)
Article (+16 cells) (+551 characters)
People (+4 cells) (+80/-7 characters)
Related Topics (+4 topics)
Topic thumbnail

Nuclera Nucleics

Nuclera Nucleics is a Cambridge, UK based DNA synthesis biotechnology company

Article

Nuclera is a DNA synthesis company working on the synthesis of long DNA strands. Nuclera's water-based DNA synthesis and automation platform is based on engineered terminal deoxynucleotidyl transferases (TdT) to enable the production of gene and genome libraries. Their TdT enzymes incorporate reversibly terminating nucleotide triphosphates of the four nucleobases. Nuclera aims to provide long-length (longer than 500 nucleotides) variant DNA and genome libraries for protein, biological pathway, and genome-scale engineering.



Patents

Description
Status
Link
Date

The use of specific terminal deoxynucleotidyl transferase (TdT) enzymes in a method of nucleic acid synthesis, to methods of synthesizing nucleic acids, and to the use of kits comprising said enzymes in a method of nucleic acid synthesis.

Pending

2/10/2016

A process for the preparation of nucleic acid by means of 3'-o-azidomethyl nucleotide triphosphate

Pending

9/9/2016

Azidomethyl ether deprotection method

Pending

1/19/2017

The use of a DNA polymerise theta (PolQ) enzyme in a method of template-independent nucleic acid synthesis.

Pending

7/29/2016

People

Name
Role
Related Golden topics

Gordon McInroy

Co-founder and CSO



Jiahao Huang

FounderCo-founder and CCO



Michael Chen

Co-founder and CTO



Infobox

Related Topics

Edits on 19 Jul 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 Jul 2018 7:47 pm

Infobox

Location
Edits on 16 Jul 2018
Golden AI"Update markets in infobox"
Golden AI edited on 16 Jul 2018 10:48 pm
Edits on 29 Jun 2018
Golden AI"Update infobox"
Golden AI edited on 29 Jun 2018 12:05 am
Edits on 1 Jun 2018
Golden AI"Updating description"
Golden AI edited on 1 Jun 2018 8:04 pm
Edits made to:
Description (+57/-25 characters)
Topic thumbnail

Nuclera Nucleics

Synthetic Biology company

Nuclera Nucleics is a DNA synthesis biotechnology company

Edits on 30 May 2018
Golden AI"Initial topic creation"
Golden AI created this topic on 30 May 2018 10:29 pm
Edits made to:
Description (+25 characters)
People (+2 cells) (+19 characters)
Categories (+1 topics)
Topic thumbnail

 Nuclera Nucleics

Synthetic Biology company

People

Name
Role
Related Golden topics

Jiahao Huang

Founder



Categories

No more activity to show.